• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AIFM3、VGLL4和WNT4在不同分期结直肠癌患者中的表达模式

Expression Pattern of AIFM3, VGLL4, and WNT4 in Patients with Different Stages of Colorectal Cancer.

作者信息

Bevanda Danijel, Racetin Anita, Kelam Nela, Filipović Natalija, Bevanda Mateo, Rudan Dimlić Marina, Budimir Jelena, Bevanda Glibo Daniela, Bevanda Ivana, Ramljak Danica, Vukojević Katarina

机构信息

Department of Gastroenterology, School of Medicine, University of Mostar, University Hospital Mostar, Bijeli Brijeg bb, 88000 Mostar, Bosnia and Herzegovina.

Department of Anatomy, Histology and Embryology, Laboratory for Early Human Development, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.

出版信息

Cancers (Basel). 2025 Jan 7;17(2):166. doi: 10.3390/cancers17020166.

DOI:10.3390/cancers17020166
PMID:39857952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763972/
Abstract

BACKGROUND/OBJECTIVES: Colorectal cancer (CRC) remains a significant health burden, and its delayed diagnosis at advanced stages leads to poor survival outcome. Detection of known and novel prognostic markers is essential. In this study, the status of likely prognostic markers-the apoptotic inducing factor (AIFM3), vestigial-like family member 4 (VGLL4), and WNT4-was evaluated.

METHODS

AIFM3, VGLL4, and WNT4 expression in CRC tissues across different stages (Dukes A-D) were analyzed using histological immunofluorescence staining and RNA sequencing analyses.

RESULTS

In advanced CRC stages, progressive loss of normal crypt architecture, reduction of goblet cells, and necrotic debris were detected along with differential expression patterns of AIFM3, VGLL4, and WNT4. AIFM3 exhibited high reactivity in the lamina propria of healthy tissue and Dukes A, but this was diminished in advanced CRC stages. VGLL4 expression, initially confined to the lamina propria, increased significantly in the epithelium of Dukes B and C, with a cytoplasmic localization pattern. WNT4 expression was elevated in the CRC epithelium across all stages, contrasting with a significant reduction in lamina propria reactivity. RNA sequencing corroborated these findings, showing significant downregulation of AIFM3 and WNT4 and upregulation of VGLL4 in CRC tissues compared to controls. Expression of AIFM3 and WNT4 showed no correlation with survival outcome, while low VGLL4 expression was correlated with better survival outcome.

CONCLUSIONS

The results suggest distinct roles for AIFM3, VGLL4, and WNT4 in CRC progression, highlighting only VGLL4 as a potential prognostic marker. Further evaluation of VGLL4 and its specific role in CRC progression remains to be elucidated.

摘要

背景/目的:结直肠癌(CRC)仍是一项重大的健康负担,其晚期的延迟诊断导致生存结局不佳。检测已知和新的预后标志物至关重要。在本研究中,对可能的预后标志物——凋亡诱导因子(AIFM3)、类 vestigial 家族成员 4(VGLL4)和 WNT4 的状态进行了评估。

方法

使用组织学免疫荧光染色和 RNA 测序分析,对不同分期(Dukes A - D)的结直肠癌组织中 AIFM3、VGLL4 和 WNT4 的表达进行分析。

结果

在晚期结直肠癌阶段,检测到正常隐窝结构逐渐丧失、杯状细胞减少和坏死碎片,同时伴随着 AIFM3、VGLL4 和 WNT4 的差异表达模式。AIFM3 在健康组织和 Dukes A 期的固有层中表现出高反应性,但在晚期结直肠癌阶段这种反应性降低。VGLL4 的表达最初局限于固有层,在 Dukes B 和 C 期的上皮中显著增加,呈细胞质定位模式。WNT4 的表达在所有阶段的结直肠癌上皮中均升高,与固有层反应性的显著降低形成对比。RNA 测序证实了这些发现,显示与对照组相比,结直肠癌组织中 AIFM3 和 WNT4 显著下调,VGLL4 上调。AIFM3 和 WNT4 的表达与生存结局无关,而低 VGLL4 表达与更好的生存结局相关。

结论

结果表明 AIFM3、VGLL4 和 WNT4 在结直肠癌进展中具有不同作用,仅突出 VGLL4 作为潜在的预后标志物。VGLL4 及其在结直肠癌进展中的具体作用仍有待进一步阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/7315c00ff0d9/cancers-17-00166-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/0991fbdc8fc1/cancers-17-00166-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/a0d59da07263/cancers-17-00166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/82874cd9f608/cancers-17-00166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/a97f698a80ca/cancers-17-00166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/5aa3f2befcb7/cancers-17-00166-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/935dd8f84973/cancers-17-00166-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/e5430f5a5df1/cancers-17-00166-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/7315c00ff0d9/cancers-17-00166-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/0991fbdc8fc1/cancers-17-00166-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/a0d59da07263/cancers-17-00166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/82874cd9f608/cancers-17-00166-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/a97f698a80ca/cancers-17-00166-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/5aa3f2befcb7/cancers-17-00166-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/935dd8f84973/cancers-17-00166-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/e5430f5a5df1/cancers-17-00166-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c224/11763972/7315c00ff0d9/cancers-17-00166-g007.jpg

相似文献

1
Expression Pattern of AIFM3, VGLL4, and WNT4 in Patients with Different Stages of Colorectal Cancer.AIFM3、VGLL4和WNT4在不同分期结直肠癌患者中的表达模式
Cancers (Basel). 2025 Jan 7;17(2):166. doi: 10.3390/cancers17020166.
2
Expression Pattern of PDE4B, PDE4D, and SFRP5 Markers in Colorectal Cancer.PDE4B、PDE4D 和 SFRP5 标志物在结直肠癌中的表达模式。
Medicina (Kaunas). 2024 Jul 25;60(8):1202. doi: 10.3390/medicina60081202.
3
WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway.肿瘤组织分泌的WNT4通过激活Wnt/β-连环蛋白信号通路促进结直肠癌的肿瘤进展。
J Exp Clin Cancer Res. 2020 Nov 23;39(1):251. doi: 10.1186/s13046-020-01774-w.
4
VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer.VGLL4 与低表达的 YAP 与结直肠癌的良好预后相关。
APMIS. 2020 Oct;128(10):543-551. doi: 10.1111/apm.13070. Epub 2020 Sep 14.
5
Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients.血清中凋亡诱导因子,线粒体相关 3(AIFM3)蛋白水平作为胆管癌患者的预后标志物。
Biomolecules. 2020 Jul 10;10(7):1021. doi: 10.3390/biom10071021.
6
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.新型预后因子 AIFM3 在乳腺癌患者中的临床意义。
BMC Cancer. 2019 May 14;19(1):451. doi: 10.1186/s12885-019-5659-4.
7
The Expression Pattern of Bcl-2 and Bax in the Tumor and Stromal Cells in Colorectal Carcinoma.Bcl-2 和 Bax 在结直肠癌肿瘤细胞和基质细胞中的表达模式。
Medicina (Kaunas). 2022 Aug 21;58(8):1135. doi: 10.3390/medicina58081135.
8
Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib.瑞戈非尼治疗的透明细胞肾细胞癌患者中RIP5和VGLL4的临床意义及表达模式
Biomedicines. 2024 Jan 10;12(1):149. doi: 10.3390/biomedicines12010149.
9
VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.VGLL4是一种转录辅因子,通过与TEADs相互作用发挥新型肿瘤抑制因子的作用。
Am J Cancer Res. 2018 Jun 1;8(6):932-943. eCollection 2018.
10
Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.食管鳞状细胞癌进展过程中VGLL4的下调
Tumour Biol. 2015 Feb;36(2):1289-97. doi: 10.1007/s13277-014-2701-7. Epub 2014 Oct 30.

引用本文的文献

1
Atypical Hippo signaling network: uncovering novel insights into head and neck cancer biology and advancements in precision intervention.非典型河马信号网络:揭示头颈癌生物学的新见解及精准干预的进展
Front Cell Dev Biol. 2025 May 23;13:1610471. doi: 10.3389/fcell.2025.1610471. eCollection 2025.

本文引用的文献

1
Colorectal cancer: Recent advances in management and treatment.结直肠癌:管理与治疗的最新进展
World J Clin Oncol. 2024 Sep 24;15(9):1136-1156. doi: 10.5306/wjco.v15.i9.1136.
2
Wnt/β-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells.Wnt/β-catenin 信号通路、上皮间质转化和结直肠癌细胞中的交联信号。
Biomed Pharmacother. 2024 Jun;175:116685. doi: 10.1016/j.biopha.2024.116685. Epub 2024 May 5.
3
Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
微卫星不稳定性与错配修复蛋白缺陷:同等的预测标志物?
Pathol Oncol Res. 2024 Apr 9;30:1611719. doi: 10.3389/pore.2024.1611719. eCollection 2024.
4
Molecular pathological classification of colorectal cancer-an update.结直肠癌的分子病理分类——更新。
Virchows Arch. 2024 Feb;484(2):273-285. doi: 10.1007/s00428-024-03746-3. Epub 2024 Feb 6.
5
Tumor microenvironment signaling and therapeutics in cancer progression.肿瘤微环境信号与癌症进展中的治疗策略。
Cancer Commun (Lond). 2023 May;43(5):525-561. doi: 10.1002/cac2.12416. Epub 2023 Apr 2.
6
Clinical study of colorectal cancer operation: Survival analysis.结直肠癌手术的临床研究:生存分析
Korean J Clin Oncol. 2020 Jun;16(1):3-8. doi: 10.14216/kjco.20002. Epub 2020 Jun 30.
7
Targeting p53 pathways: mechanisms, structures, and advances in therapy.靶向 p53 通路:机制、结构和治疗进展。
Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1.
8
Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.结直肠癌中的 Wnt 信号通路:致病作用和治疗靶点。
Mol Cancer. 2022 Jul 14;21(1):144. doi: 10.1186/s12943-022-01616-7.
9
Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies.结直肠癌:致癌作用、全球流行病学、当前挑战、风险因素、预防与治疗策略综述
Cancers (Basel). 2022 Mar 29;14(7):1732. doi: 10.3390/cancers14071732.
10
Risk Factors for the Diagnosis of Colorectal Cancer.结直肠癌诊断的危险因素。
Cancer Control. 2022 Jan-Dec;29:10732748211056692. doi: 10.1177/10732748211056692.